Real-time enrollment status for this homeostatic iron regulator gene-related hereditary hemochromatosis clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 2:23 PM UTC
| NCT Number | NCT07332091 |
| Recruiting Status | Recruiting |
| Condition | Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis |
| Phase | PHASE2 |
| Target Enrollment | 84 participants |
| Active Locations | 20 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | September 16, 2026 (3 weeks ago) |
As of October 13, 2026: Clinical trial NCT07332091 is currently recruiting participants. This phase2 study for homeostatic iron regulator gene-related hereditary hemochromatosis is actively seeking new participants at 20 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07332091 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07332091 was last updated 3 weeks ago (September 16, 2026). HelloStudys verifies this status automatically.